根据该协议,Catalent将向TFF提供其扩大规模的专业知识和制造能力,作为其首选的开发和制造合作伙伴,Catalent将能够向其客户提供TFF技术,这有可能增加...查看全文
美港电讯APP2020-09-24 21:21
TFF制药(TFFP.O):在实验中,发现含亮氨酸的瑞德西韦干粉制剂能更持久地从肺释放到到血浆,公司正与吉利德科学(GILD.O)就此研究结果进行讨论。$TFF Pharmaceuticals(TFFP)$ $吉利德科学(GILD)$ (来自美港电讯APP)查看全文
chuminhua2020-08-14 10:55
8月13日,TFF Pharmaceuticals,Inc.$TFF Pharmaceuticals(TFFP)$ 是一家临床阶段的生物制药公司,专注于根据其专利的薄膜冷冻(TFF)技术平台开发和商业化创新药物产品,宣布已与UNION therapeutics签订了一项全球独家许可协议,将其TFF技术与氯硝柳胺(niclosamide)联合使用。根据协议条款,UNI...查看全文
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-20-035269 Act: 34 Size: 146 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-20-035277 Act: 34 Size: 1 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001213900-20-035288 Act: 33 Size: 1 MB 网页链接
$TFF Pharmaceuticals(TFFP)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-20-030487 Act: 33 Size: 87 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, item 5.07 Accession Number: 0001213900-20-029506 Act: 34 Size: 28 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 1.01 and 5.02 Accession Number: 0001213900-20-028933 Act: 34 Size: 23 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-20-028935 Size: 9 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-002460 Act: 33 Size: 1 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-20-025714 Act: 33 Size: 313 KB 网页链接
$TFF Pharmaceuticals(TFFP)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-20-024262 Act: 34 Size: 359 KB 网页链接